NATIONAL BOARD OF EXAMINATIONS
JUNE 2020
PATHOLOGY
PAPER-II
--- Content provided by FirstRanker.com ---
TIME: 3 HOURSPATH/J/20/32/III
MAX. MARKS: 100
Important Instructions:
Attempt al questions in order.
--- Content provided by FirstRanker.com ---
Each question carries 10 marks.Read the question careful y and answer to the point neatly and legibly.
Do not leave any blank pages between two answers.
Indicate the question number correctly for the answer in the margin space.
Answer al the parts of a single question together.
--- Content provided by FirstRanker.com ---
Start the answer to a question on a fresh page or leave adequate space between twoanswers.
Draw table/diagrams/flowcharts wherever appropriate
Write short notes on:
1. Enumerate the Chapel Hil Classification of vasculitis. Discuss smal
--- Content provided by FirstRanker.com ---
vessel vasculitis.5+5
2. Classify sino-nasal neoplasms. Discuss the newer entities.
5+5
3. a) Sclerosing adenomatoid transformation of Spleen (SANT).
--- Content provided by FirstRanker.com ---
b) Solid Pseudopapil ary Epithelial Neoplasm (SPEN).5+5
4. Discuss the risk stratification in GIST. Discuss role of IHC and molecular
diagnostics in the neoplasm.
5+5
--- Content provided by FirstRanker.com ---
5. Enumerate the indications of muscle biopsy. Discuss the role of routinestains and Electron Microscopy in identifying muscle pathology.
5+5
6. Classify renal graft rejection. Discuss Banff classification of renal
transplant pathology.
--- Content provided by FirstRanker.com ---
5+57. Classify vesico-bul ous lesion of skin. Elaborate the role of
immunofluorescence in the diagnosis.
5+5
8. Classify low grade B Cel lymphomas. Discuss the role of histology and
--- Content provided by FirstRanker.com ---
immunohistochemistry in classifying them.5+5
9. a) Histologic variants of ameloblastoma.
b) Immunological classification of triple negative breast cancer.
5+5
--- Content provided by FirstRanker.com ---
10. a) Translocation associated renal cel carcinomas.b) Molecular classification of endometrial cancer.
5+5
************
POSSESSION/USE OF CELL PHONES OR ANY SUCH ELECTRONIC GADGETS IS NOT PERMITTED INSIDE THE EXAMINATION
--- Content provided by FirstRanker.com ---
HALL.